Evidence map›Paper›PMID 34961217›Full record

ArticlePlants (Basel, Switzerland)2021

Efficiency and Persistence of Movento

Thomas Armand, Luâna Korn, Elodie Pichon, Marlène Souquet, Mélissandre Barbet, Jean-Laurent Martin, Magalie Devavry, Emmanuel Jacquot

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Thomas ArmandPHIM Plant Health Institute Montpellier, University of Montpellier, INRAE, CIRAD, Institut Agro, IRD, CEDEX 5, 34398 Montpellier, France.
Luâna KornPHIM Plant Health Institute Montpellier, University of Montpellier, INRAE, CIRAD, Institut Agro, IRD, CEDEX 5, 34398 Montpellier, France.
Elodie PichonPHIM Plant Health Institute Montpellier, University of Montpellier, INRAE, CIRAD, Institut Agro, IRD, CEDEX 5, 34398 Montpellier, France.
Marlène SouquetPHIM Plant Health Institute Montpellier, University of Montpellier, INRAE, CIRAD, Institut Agro, IRD, CEDEX 5, 34398 Montpellier, France.
Mélissandre BarbetPHIM Plant Health Institute Montpellier, University of Montpellier, INRAE, CIRAD, Institut Agro, IRD, CEDEX 5, 34398 Montpellier, France.
Jean-Laurent MartinBayer S.A.S./Bayer CropScience, 16 rue Jean Marie Leclair, CS 90106, CEDEX 09, 69266 Lyon, France.
Magalie DevavryBayer S.A.S./Bayer CropScience, 16 rue Jean Marie Leclair, CS 90106, CEDEX 09, 69266 Lyon, France.
Emmanuel JacquotPHIM Plant Health Institute Montpellier, University of Montpellier, INRAE, CIRAD, Institut Agro, IRD, CEDEX 5, 34398 Montpellier, France.
Centre de Coopération Internationale en Recherche Agronomique pour le Développement · FRBayer (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonicotinoids are widely used to protect fields against aphid-borne viral diseases. The recent ban of these chemical compounds in the European Union has strongly impacted rapeseed and sugar beet growing practices. The poor sustainability of other insecticide families and the low efficiency of prophylactic methods to control aphid populations and pathogen introduction strengthen the need to characterize the efficiency of new plant protection products targeting aphids. In this study, the impact of Movento

Indexed as

aphicid treatmentbeet mild yellowing virusMyzus persicaeplant-virus-aphid interactionsPolerovirusturnip yellows virus

Identifiers

PMID34961217
PMCPMC8708080
OpenAlexW4200029248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.